Medical Weight Loss for Reading, Pennsylvania Residents
Reading, Pennsylvania residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month, serving Reading through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Reading Residents Choose New Hope Weight Loss
Some patients in Reading are weighing semaglutide against tirzepatide, and that is a conversation worth having with a doctor, not a website. Dr. Anjmun Sharma helps you understand the trade-offs, the cost difference between $166 and $233 a month, and what the trial data actually showed, with semaglutide averaging about 15 to 17 percent body-weight loss and tirzepatide reaching up to 22.5 percent at qualifying doses. These are compounded, not brand-identical, and results vary, so the choice should be informed.
Reading patients are cared for entirely through telehealth from our Costa Mesa, California clinic. There is no travel, your consultation with Dr. Sharma, prescription, and follow-ups all happen by secure video.
We treat Reading patients the way we treat everyone, with one licensed physician overseeing your care and telehealth carrying that care across Pennsylvania instead of asking you to drive to California. We care for patients throughout Downtown and the greater Berks County area, with bilingual Spanish care. Semaglutide starts from $166 a month, or $499 for the 90-day program, and tirzepatide from $233 a month, the same pricing for every Pennsylvania patient.
You can start this week from anywhere in Pennsylvania, because telehealth removes the drive, the parking, and the weeks of waiting that a local clinic would require. If you would rather spread payments out, Reading patients can use Klarna or Affirm at checkout instead of paying the full cost at once. Pennsylvania is one of the most populous states in the country, and New Hope Weight Loss serves patients across it by secure telehealth from our Costa Mesa, California clinic.
GLP-1 Weight Loss Programs Available
Begin your reset: semaglutide, from $166/mo
The 90-Day Metabolic Reset gives Reading patients a structured three-month plan with semaglutide, the active ingredient shared with Wegovy and Ozempic. Choose $166 a month or $499 for the whole 90 days. In trials of the branded drug, the average was around 15 to 17 percent body-weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, and results vary.
Go further: tirzepatide, from $233/mo
Tirzepatide hits both GLP-1 and GIP receptors for a dual effect. Qualifying doses in branded-drug trials reached up to 22.5 percent loss, which is not what most patients should expect. It carries the same active ingredient as Mounjaro and Zepbound.
Each plan begins with a $119 physician review. Medication is billed separately. HSA, FSA, Klarna, and Affirm accepted.
How Telehealth Works for Reading
Step 1 of 4: Answer the intake quiz online, sharing your weight history, current health, and what you hope to reach.
Step 2 of 4: Dr. Sharma reviews your responses and connects by secure video, usually within 48 hours, to confirm whether compounded semaglutide or tirzepatide is a reasonable option for you.
Step 3 of 4: A state-licensed 503(a) pharmacy ships your prescription to your Reading address in insulated cold-pack packaging.
Step 4 of 4: Follow-up visits run by video, so you and Dr. Sharma adjust as needed without travel anywhere in .
Frequently Asked Questions, Reading
Where is the New Hope Weight Loss location serving Reading?
The location serving Reading is our Costa Mesa, California clinic, which is our only physical site. We care for Reading, Pennsylvania patients through telehealth rather than a local office. Dr. Anjmun Sharma confirms your eligibility for a compounded GLP-1 plan during a private video consult.
Is remote care a real option for Reading patients?
It is the standard for Reading. The whole program runs on telehealth, so consults, follow-ups, and support happen wherever you are. When Dr. Sharma approves you, compounded medication ships to Reading in cold-pack packaging engineered to keep it at a safe temperature in transit.
How much does a Reading patient pay overall?
The physician review is $119. Compounded semaglutide is offered from $166 monthly, or $499 for 90 days, and tirzepatide from $233 monthly. The medication is billed separately from the visit. We accept HSA, FSA, Klarna, and Affirm, and we apply no distance surcharge for Reading patients.
What areas of Reading do you serve?
We serve patients from across Reading by telehealth, including Downtown and the greater Berks County area, with bilingual Spanish care.
What does treatment cost for Reading patients?
The same flat pricing nationwide: a $119 physician visit, compounded semaglutide from $166/month, and compounded tirzepatide from $233/month, with medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, and there is no distance surcharge for Reading.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Reading, Pennsylvania by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.